Medwise Consultancy Ltd iXBRL


Relate AccountsProduction v2.1.19 v2.1.19 2017-11-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The company's principal activity during the year continued to be providing medical locum services for NHS. 25 January 2019 1 1 09285134 2018-10-31 09285134 2017-10-31 09285134 2016-10-31 09285134 2017-11-01 2018-10-31 09285134 2016-11-01 2017-10-31 09285134 uk-bus:PrivateLimitedCompanyLtd 2017-11-01 2018-10-31 09285134 uk-bus:AbridgedAccounts 2017-11-01 2018-10-31 09285134 uk-core:ShareCapital 2018-10-31 09285134 uk-core:ShareCapital 2017-10-31 09285134 uk-core:RetainedEarningsAccumulatedLosses 2018-10-31 09285134 uk-core:RetainedEarningsAccumulatedLosses 2017-10-31 09285134 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2018-10-31 09285134 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2017-10-31 09285134 uk-bus:FRS102 2017-11-01 2018-10-31 09285134 uk-core:FurnitureFittingsToolsEquipment 2017-11-01 2018-10-31 09285134 2017-11-01 2018-10-31 09285134 uk-bus:Director1 2017-11-01 2018-10-31 09285134 uk-bus:AuditExempt-NoAccountantsReport 2017-11-01 2018-10-31 xbrli:pure iso4217:GBP xbrli:shares
Company Number: 09285134
 
 
Medwise Consultancy Ltd
 
Unaudited Abridged Financial Statements
 
for the year ended 31 October 2018
Medwise Consultancy Ltd
Company Number: 09285134
ABRIDGED BALANCE SHEET
as at 31 October 2018

2018 2017
Notes £ £
 
Fixed Assets
Tangible assets 4 1,329 1,281
───────── ─────────
 
Current Assets
Cash and cash equivalents 23,737 51,181
Creditors: Amounts falling due within one year (14,078) (48,536)
───────── ─────────
Net Current Assets 9,659 2,645
───────── ─────────
Total Assets less Current Liabilities 10,988 3,926
═════════ ═════════
Capital and Reserves
Called up share capital 100 100
Profit and Loss Account 10,888 3,826
───────── ─────────
Equity attributable to owners of the company 10,988 3,926
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Director's Report.
           
For the financial year ended 31 October 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 25 January 2019
           
________________________________          
Dr Aasma Afshin          
Director          



Medwise Consultancy Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the year ended 31 October 2018

   
1. GENERAL INFORMATION
 
Medwise Consultancy Ltd is a company limited by shares incorporated in United Kingdom. The registered office of the company is 228 Kingsway, Gatley, Cheadle, Manchester, SK8 4PB , United Kingdom. The financial statements have been presented in Pound Sterling (£) which is also the functional currency of the company.
         
2. ACCOUNTING POLICIES
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company’s financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 31 October 2018 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared under the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets. The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Cash flow statement
The company has availed of the exemption in FRS 102 Section 1A from the requirement to prepare a Cash Flow Statement because it is classified as a small company.
 
Turnover
Turnover comprises the invoiced value of services supplied by the company, exclusive of trade discounts.
 
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible fixed assets, less their estimated residual value, over their expected useful lives as follows:
 
  Fixtures, fittings and equipment - 15% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation and deferred taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Balance Sheet date.
 
Share capital of the company
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. EMPLOYEES
 
The average monthly number of employees, including director, during the year was 1 (2017 -1).
       
4. TANGIBLE FIXED ASSETS
  Fixtures, Total
  fittings and  
  equipment  
  £ £
Cost
At 1 November 2017 2,021 2,021
Additions 282 282
  ───────── ─────────
At 31 October 2018 2,303 2,303
  ───────── ─────────
Depreciation
At 1 November 2017 740 740
Charge for the year 234 234
  ───────── ─────────
At 31 October 2018 974 974
  ───────── ─────────
Net book value
At 31 October 2018 1,329 1,329
  ═════════ ═════════
At 31 October 2017 1,281 1,281
  ═════════ ═════════
       
5. CAPITAL COMMITMENTS
 
The company had no material capital commitments at the year-ended 31 October 2018.
   
6. POST-BALANCE SHEET EVENTS
 
There have been no significant events affecting the company since the year-end.